Division of Oncology and Hematology
The Division of Oncology and Hematology is interested in the diagnosis and treatment of all malignancies (cancers) that occur in adults. Treatment may include chemotherapy and immunotherapy, including vaccines and radioimmunoconjugates. High dose therapy with bone marrow or peripheral stem cell transplantation is also available. The division boasts a world-renowned peripheral stem cell transplantation program, directed by Anne Kessinger, M.D., who pioneered the technique. The Division of Oncology's physicians specialize in many types of cancers including: lymphomas, leukemia, urologic, breast, lung, gastric and pancreatic, brain cancer, melanoma, hepatocellular and solid tumors. Care for patients with incurable cancers is also available.
Hematology is interested in the treatment of patients with blood diseases such as anemia, bleeding disorders, and clotting problems. The Division is home to the Nebraska Regional Hemophilia Treatment Center which treats adult and pediatric patients from across the state with bleeding disorders.
The Division of Oncology and Hematology is a member of the National Comprehensive Cancer Network (NCCN), an alliance of the nation's 21 leading cancer centers. NCCN centers develop and institute standards of care for the treatment of cancer and perform outcomes research with the good of ensuring the delivery of high quality, cost-effective services to cancer patients nationwide.
Division Chief: Julie M. Vose, M.D.
Administrator: Lisa Muschall
987680 Nebraska Medical Center
Omaha, NE 68198-7680
Fellowship Program Director: R. Gregory Bociek, M.D.
Fellowship Coordinator: Shaun Capurro
- Breast Cancer
Stem Cell Transplantation
- Thoracic Oncology
- Urologic Oncology
- Partners & Facilities